In an impressive leap forward for medical technology, JiviAI, a pioneering healthcare firm based in Gurugram, has announced that its advanced language model, Jivi MedX, has outstripped industry giants like Google’s Med-PaLM 2 and OpenAI’s GPT-4. Scoring an astonishing 91.65 across nine critical benchmark categories, Jivi MedX is setting new standards in the application of AI in medicine.

The stellar performance of Jivi MedX across all benchmark categories not only underscores its robust capability in understanding and generating medical language but also marks a significant milestone in medical AI. This innovation is a result of the visionary leadership of Ankur Jain, former chief product officer at BharatPe, and G V Sanjay Reddy, Chairman of Reddy Ventures. Their combined expertise in product development and strategic business management has positioned JiviAI at the forefront of the healthcare technology sector.

Jivi MedX is engineered to enhance the diagnostic process by analyzing patient records and symptoms with unprecedented accuracy, aiding physicians in delivering faster and more precise diagnoses. This technology promises to bridge communication gaps in healthcare settings by simplifying complex medical terminologies into patient-friendly language, thereby improving patient engagement in their own care processes.

With plans to officially roll out Jivi MedX in August 2024, JiviAI is actively seeking collaboration with global healthcare providers, research bodies, and governmental agencies to expand the reach and efficacy of their breakthrough AI model.

As JiviAI gears up for the global launch of Jivi MedX, the healthcare community watches with anticipation, expecting this innovation to not only enhance patient outcomes but also inspire further technological advancements within India’s growing tech industry.